Financials

  • Market Capitalization 41.04 M
  • Employee 17
  • Founded 2009
  • CEO N/A
  • Website www.renovorx.com
  • Headquarter Delaware, United States
  • FIGI BBG005XWWZK6
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.63
Price to sales ratio
26.43

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4375
PDSB
PDS Biotechnology Corporation - Common Stock
0.75 USD-2.60%-11.76%-30.56%-38.52%41.86 M USD
4382
VERU
Veru Inc. - Common Stock
2.56 USD-7.91%-9.54%-15.23%+7.11%41.09 M USD
4396
GRCE
Grace Therapeutics, Inc. - Common Stock
2.43 USD-0.82%-4.33%+10.45%-38.94%39.55 M USD
4399
LTRN
Lantern Pharma Inc. - Common Stock
3.46 USD-3.89%-11.96%-13.72%-17.42%39.11 M USD

Frequently asked questions about RenovoRx, Inc. - Common Stock

What is the RenovoRx, Inc. - Common Stock stock price today?

The current price of RenovoRx, Inc. - Common Stock (RNXT) is 0.91. Over the past 24 hours, the stock has changed by -2.15%. Follow the RNXT chart for real-time price dynamics.

What is the stock ticker of RenovoRx, Inc. - Common Stock?

RenovoRx, Inc. - Common Stock trades under the ticker RNXT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is RenovoRx, Inc. - Common Stock stock going up?

RNXT has changed by -2.15% over the last week, +8.33% over the last month, and -34.06% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was RenovoRx, Inc. - Common Stock net income for the last quarter?

RenovoRx, Inc. - Common Stock reported net income of -3.52 M for the last quarter. The previous quarter showed -2.94 M, which means net income changed by -19.72%.

How many employees does RenovoRx, Inc. - Common Stock have?

As of the latest available data, RenovoRx, Inc. - Common Stock has 17 employees. Workforce size can provide additional context about the company's scale and operations.

What is RenovoRx, Inc. - Common Stock EBITDA?

RenovoRx, Inc. - Common Stock EBITDA is -3.47 M, and its EBITDA margin is -615.99%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy RenovoRx, Inc. - Common Stock stock?

You can buy RenovoRx, Inc. - Common Stock (RNXT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in RenovoRx, Inc. - Common Stock stock?

Investing in RenovoRx, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RNXT chart and related analysis on metatrader.com as part of your research.

News